Rituximab-induced HMGB1 release is associated with inhibition of STAT3 activity in human diffuse large B-cell lymphoma
View/ Open
Volume
6
Pagination
27816 - 27831
DOI
10.18632/oncotarget.4816
Journal
ONCOTARGET
Issue
ISSN
1949-2553